Professor Claude M. Wischik, co-founder and Executive Chairman of TauRx Therapeutics, along with colleagues at the University of Aberdeen, has devoted nearly 30 years to investigating the structure and role of tau tangles in the development of Alzheimer’s, frontotemporal dementia and other neurodegenerative diseases. Prof. Wischik discovered that the neurofibrillary tangles seen in Alzheimer’s disease are made of sub-units of the tau protein and he and his team have published extensively in the field.
Filter by year:All 2021 2020 2019 2018 2017 2016 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2001 2000 1998 1997 1996 1995 1994 1993 1992 1991 1990 1988 1986 1985
Maina, M.B., et al (2021) Oxidative stress conditions result in trapping of PHF-core tau (297-391) intermediates. Available at: Cells
Al-Hilaly, Y.K. et al. (2020) Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain. Available at FEBS Letters
Arastoo, M, et al, (2020) Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics. Available at: International Journal of Molecular Sciences
Cranston, A.L., et al (2020) Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s Disease and Frontotemporal Lobar Degeneration. Available at: Brain Communications.
Hernandes-Alejandro, M., et al, (2020) Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease. Available at: Journal of Alzheimer's Disease